Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roderich E Schwarz

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Chinese Medical Journal|January 24, 2014
Evaluation of para-aortic nodal dissection for locoregionally advanced gastric cancer with 1-3 involved para-aortic nodesChanghua Zhang, Yulong He, Roderich E Schwarz, et al.
BMC Cancer|January 14, 2011
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancerNiranjan Awasthi, Amanda Kirane, Margaret A Schwarz, et al.
Plos One|February 23, 2017
A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinomaMd Sazzad Hassan, Niranjan Awasthi, Jun Li, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 10, 2013
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statementRoderich E Schwarz, Jordan D Berlin, Heinz J Lenz, et al.
World Journal of Surgical Oncology|April 24, 2012
Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for a duodenal obstructionJean J Bao, John C Mansour, Robert D Timmerman, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 2, 2010
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statementRoderich E Schwarz, Ghassan K Abou-Alfa, Jeffrey F Geschwind, et al.
Journal of Cellular and Molecular Medicine|April 4, 2019
Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancerNiranjan Awasthi, Amanda J Mikels-Vigdal, Erin Stefanutti, et al.
Scientific Reports|November 28, 2019
Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinomaMd Sazzad Hassan, Fiona Williams, Niranjan Awasthi, et al.
Annals of Surgical Oncology|March 7, 2003
Quality of life in patients with colorectal metastasis and intrahepatic chemotherapySarah L Blair, Marcia Grant, David Z J Chu, et al.
Cancer Letters|June 3, 2019
Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancerNiranjan Awasthi, David Kronenberger, Alexis Stefaniak, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Chinese Medical Journal|January 24, 2014
Evaluation of para-aortic nodal dissection for locoregionally advanced gastric cancer with 1-3 involved para-aortic nodesChanghua Zhang, Yulong He, Roderich E Schwarz, et al.
BMC Cancer|January 14, 2011
Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancerNiranjan Awasthi, Amanda Kirane, Margaret A Schwarz, et al.
Plos One|February 23, 2017
A novel intraperitoneal metastatic xenograft mouse model for survival outcome assessment of esophageal adenocarcinomaMd Sazzad Hassan, Niranjan Awasthi, Jun Li, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|January 10, 2013
Systemic cytotoxic and biological therapies of colorectal liver metastases: expert consensus statementRoderich E Schwarz, Jordan D Berlin, Heinz J Lenz, et al.
World Journal of Surgical Oncology|April 24, 2012
Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for a duodenal obstructionJean J Bao, John C Mansour, Robert D Timmerman, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|July 2, 2010
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statementRoderich E Schwarz, Ghassan K Abou-Alfa, Jeffrey F Geschwind, et al.
Journal of Cellular and Molecular Medicine|April 4, 2019
Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancerNiranjan Awasthi, Amanda J Mikels-Vigdal, Erin Stefanutti, et al.
Scientific Reports|November 28, 2019
Combination effect of lapatinib with foretinib in HER2 and MET co-activated experimental esophageal adenocarcinomaMd Sazzad Hassan, Fiona Williams, Niranjan Awasthi, et al.
Annals of Surgical Oncology|March 7, 2003
Quality of life in patients with colorectal metastasis and intrahepatic chemotherapySarah L Blair, Marcia Grant, David Z J Chu, et al.
Cancer Letters|June 3, 2019
Dual inhibition of the PI3K and MAPK pathways enhances nab-paclitaxel/gemcitabine chemotherapy response in preclinical models of pancreatic cancerNiranjan Awasthi, David Kronenberger, Alexis Stefaniak, et al.
Pageof 11